Literature DB >> 19332109

Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1.

P Singer1, B K Yee, J Feldon, T Iwasato, S Itohara, T Grampp, G Prenosil, D Benke, H Möhler, D Boison.   

Abstract

Converging evidence from pharmacological and molecular studies has led to the suggestion that inhibition of glycine transporter 1 (GlyT1) constitutes an effective means to boost N-methyl-d-aspartate receptor (NMDAR) activity by increasing the extra-cellular concentration of glycine in the vicinity of glutamatergic synapses. However, the precise extent and limitation of this approach to alter cognitive function, and therefore its potential as a treatment strategy against psychiatric conditions marked by cognitive impairments, remain to be fully examined. Here, we generated mutant mice lacking GlyT1 in the entire forebrain including neurons and glia. This conditional knockout system allows a more precise examination of GlyT1 downregulation in the brain on behavior and cognition. The mutation was highly effective in attenuating the motor-stimulating effect of acute NMDAR blockade by phencyclidine, although no appreciable elevation in NMDAR-mediated excitatory postsynaptic currents (EPSC) was observed in the hippocampus. Enhanced cognitive performance was observed in spatial working memory and object recognition memory while spatial reference memory and associative learning remained unaltered. These findings provide further credence for the potential cognitive enhancing effects of brain GlyT1 inhibition. At the same time, they indicated potential phenotypic differences when compared with other constitutive and conditional GlyT1 knockout lines, and highlighted the possibility of a functional divergence between the neuronal and glia subpopulations of GlyT1 in the regulation of learning and memory processes. The relevance of this distinction to the design of future GlyT1 blockers as therapeutic tools in the treatment of cognitive disorders remains to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332109      PMCID: PMC2692764          DOI: 10.1016/j.neuroscience.2009.03.056

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  79 in total

1.  Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex.

Authors:  Maria Sol Kruse; Joël Prémont; Marie-Odile Krebs; Thérèse M Jay
Journal:  Eur Neuropsychopharmacol       Date:  2009-01-31       Impact factor: 4.600

2.  Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory.

Authors:  N Pitsikas; A Boultadakis; N Sakellaridis
Journal:  Neuroscience       Date:  2008-04-07       Impact factor: 3.590

Review 3.  The inhibitory neuronal glycine receptor.

Authors:  C Béchade; C Sur; A Triller
Journal:  Bioessays       Date:  1994-10       Impact factor: 4.345

Review 4.  Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1.

Authors:  Hanns Möhler; Uwe Rudolph; Detlev Boison; Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Pharmacol Biochem Behav       Date:  2008-03-13       Impact factor: 3.533

5.  Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour.

Authors:  Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2009-03-17       Impact factor: 4.600

6.  Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.

Authors:  Denis Boulay; Philippe Pichat; Gihad Dargazanli; Genevieve Estenne-Bouhtou; Jean Paul Terranova; Nancy Rogacki; Jeanne Stemmelin; Annick Coste; Christophe Lanneau; Christophe Desvignes; Caroline Cohen; Richard Alonso; Xavier Vigé; Bruno Biton; Régis Steinberg; Mireille Sevrin; Florence Oury-Donat; Pascal George; Olivier Bergis; Guy Griebel; Patrick Avenet; Bernard Scatton
Journal:  Pharmacol Biochem Behav       Date:  2008-06-24       Impact factor: 3.533

7.  Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine.

Authors:  Kenji Hashimoto; Yuko Fujita; Tamaki Ishima; Shigeyuki Chaki; Masaomi Iyo
Journal:  Eur Neuropsychopharmacol       Date:  2007-09-04       Impact factor: 4.600

8.  Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

Authors:  Mark D Black; Geoffrey B Varty; Michal Arad; Segev Barak; Amaya De Levie; Denis Boulay; Philippe Pichat; Guy Griebel; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

9.  The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice.

Authors:  Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2008-08-29       Impact factor: 4.530

10.  Dopamine modulation of hippocampal-prefrontal cortical interaction drives memory-guided behavior.

Authors:  Yukiori Goto; Anthony A Grace
Journal:  Cereb Cortex       Date:  2007-10-12       Impact factor: 5.357

View more
  8 in total

1.  Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Authors:  Philipp Singer; Detlev Boison; Hanns Möhler; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-19       Impact factor: 4.600

2.  Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior.

Authors:  Michelle C Potter; Greg I Elmer; Richard Bergeron; Edson X Albuquerque; Paolo Guidetti; Hui-Qiu Wu; Robert Schwarcz
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 3.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

4.  Intact working memory in the absence of forebrain neuronal glycine transporter 1.

Authors:  Sylvain Dubroqua; Lucas Serrano; Detlev Boison; Joram Feldon; Pascual A Gargiulo; Benjamin K Yee
Journal:  Behav Brain Res       Date:  2012-02-08       Impact factor: 3.332

5.  Deletion of forebrain glycine transporter 1 enhances conditioned freezing to a reliable, but not an ambiguous, cue for threat in a conditioned freezing paradigm.

Authors:  Sylvain Dubroqua; Philipp Singer; Benjamin K Yee
Journal:  Behav Brain Res       Date:  2014-07-18       Impact factor: 3.332

6.  Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates.

Authors:  S A Castner; N V Murthy; K Ridler; H Herdon; B M Roberts; D P Weinzimmer; Y Huang; M Q Zheng; E A Rabiner; R N Gunn; R E Carson; G V Williams; M Laruelle
Journal:  Neuropsychopharmacology       Date:  2014-02-03       Impact factor: 7.853

7.  D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.

Authors:  Toshiharu Shimazaki; Ayaka Kaku; Shigeyuki Chaki
Journal:  Psychopharmacology (Berl)       Date:  2010-03-03       Impact factor: 4.530

Review 8.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.